相关实验视频

Updated: Jul 3, 2025

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

Published on: March 17, 2016

口服SERD是一种针对雌激素受体阳性乳腺癌的新型内分泌疗法

Niraj Neupane¹, Sawyer Bawek², Sayuri Gurusinghe²

¹Department of Internal Medicine, Rochester General Hospital, Rochester, NY 14621, USA.

|February 10, 2024

概括

新的口服选择性雌激素受体降解剂 (SERD) 为雌激素受体阳性 (ER +) 乳腺癌提供了改进的治疗选择. 这些先进的疗法可以对抗内分泌抵抗,并提高患者的舒适性,而不是老的注射.

科学领域:

在瘤学瘤学.
药理学药理学是指药理学的学科.
内分泌学在内分泌学.

背景情况:

雌激素受体阳性 (ER+) 乳腺癌是全球普遍存在的恶性瘤,通常用内分泌疗法治疗.
耐药性,特别是由于ESR1突变,在ER+乳腺癌管理中构成了重大临床挑战.
第一代选择性雌激素受体降解剂 (SERDs) 像富尔韦斯特兰特一样表现出活性,但具有诸如低生物可用性和注射要求等局限性.

研究的目的:

审查口服选择性雌激素受体降解剂 (SERD) 的发展和当前状态.
讨论第二代口服SERD与传统注射形式的优势.
探索口服SERD在治疗ER+乳腺癌中的未来前景.

主要方法:

关于SERDs的临床前和临床研究的文献综述.
对口服SERDs的药理动力学和药理动力学数据的分析.
对晚期和早期ER+乳腺癌的临床试验结果的检查.

主要成果:

第二代口服SERD证明了口服生物利用率和药理动力学的改善.
几种口服SERD正在进行ER+乳腺癌的III期临床试验.
这些药物旨在克服抵抗机制,包括ESR1突变.

结论:

口服SERD代表了ER+乳腺癌内分泌治疗的重大进展.
改善药物输送和疗效预计将改善患者的治疗结果.
目前正在进行的临床试验将确定口服SERD在各种治疗环境中的作用.

关键词:

这就是SERDs.乳腺癌乳腺癌乳腺癌内分泌疗法内分泌疗法具有雌激素受体阳性的人.通过口腔的口腔口腔.电阻的电阻是指电阻的电阻选择性的雌激素受体降解剂

更多相关视频

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...